135 related articles for article (PubMed ID: 16952297)
21. A population of in vivo anergized T cells with a lower activation threshold for the induction of CD25 exhibit differential requirements in mobilization of intracellular calcium and mitogen-activated protein kinase activation.
Utting O; Teh SJ; Teh HS
J Immunol; 2000 Mar; 164(6):2881-9. PubMed ID: 10706673
[TBL] [Abstract][Full Text] [Related]
22. Invariant NKT cell anergy is induced by a strong TCR-mediated signal plus co-stimulation.
Iyoda T; Ushida M; Kimura Y; Minamino K; Hayuka A; Yokohata S; Ehara H; Inaba K
Int Immunol; 2010 Nov; 22(11):905-13. PubMed ID: 21118907
[TBL] [Abstract][Full Text] [Related]
23. Induction of interleukin 12 responsiveness is impaired in anergic T lymphocytes.
Quill H; Bhandoola A; Trinchieri G; Haluskey J; Peritt D
J Exp Med; 1994 Mar; 179(3):1065-70. PubMed ID: 7906705
[TBL] [Abstract][Full Text] [Related]
24. The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning.
Gonzalez M; Quezada SA; Blazar BR; Panoskaltsis-Mortari A; Rudensky AY; Noelle RJ
J Immunol; 2002 Nov; 169(10):5581-9. PubMed ID: 12421935
[TBL] [Abstract][Full Text] [Related]
25. Tolerogenic Donor-Derived Dendritic Cells Risk Sensitization In Vivo owing to Processing and Presentation by Recipient APCs.
Smyth LA; Ratnasothy K; Moreau A; Alcock S; Sagoo P; Meader L; Tanriver Y; Buckland M; Lechler R; Lombardi G
J Immunol; 2013 May; 190(9):4848-60. PubMed ID: 23536635
[TBL] [Abstract][Full Text] [Related]
26. The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model.
Dey B; Yang YG; Preffer F; Shimizu A; Swenson K; Dombkowski D; Sykes M
Transplantation; 1999 Jul; 68(1):141-9. PubMed ID: 10428282
[TBL] [Abstract][Full Text] [Related]
27. Effect of staphylococcal enterotoxin B-induced anergy on cytokine gene expression: anergy-sensitive and resistant mRNA expression.
Koide Y; Uchijima M; Yoshida A; Yoshida TO
J Interferon Cytokine Res; 1996 Mar; 16(3):225-36. PubMed ID: 8697145
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional modulation of TCR, Notch and Wnt signaling pathways in SEB-anergized CD4+ T cells.
Kurella S; Yaciuk JC; Dozmorov I; Frank MB; Centola M; Farris AD
Genes Immun; 2005 Oct; 6(7):596-608. PubMed ID: 16034473
[TBL] [Abstract][Full Text] [Related]
29. Induction of donor-specific T cell anergy by portal venous injection of allogeneic cells.
Sugiura K; Kato K; Hashimoto F; Jin T; Amoh Y; Yamamoto Y; Morita H; Okumura K; Ikehara S
Immunobiology; 1997 Nov; 197(5):460-77. PubMed ID: 9413746
[TBL] [Abstract][Full Text] [Related]
30. Signals and sequences that control CD28 localization to the central region of the immunological synapse.
Sanchez-Lockhart M; Graf B; Miller J
J Immunol; 2008 Dec; 181(11):7639-48. PubMed ID: 19017952
[TBL] [Abstract][Full Text] [Related]
31. Dynamic equilibrium of B7-1 dimers and monomers differentially affects immunological synapse formation and T cell activation in response to TCR/CD28 stimulation.
Bhatia S; Sun K; Almo SC; Nathenson SG; Hodes RJ
J Immunol; 2010 Feb; 184(4):1821-8. PubMed ID: 20065109
[TBL] [Abstract][Full Text] [Related]
32. T-cell anergy and altered T-cell receptor signaling: effects on autoimmune disease.
Salojin KV; Zhang J; Madrenas J; Delovitch TL
Immunol Today; 1998 Oct; 19(10):468-73. PubMed ID: 9785671
[TBL] [Abstract][Full Text] [Related]
33. Defective TCR-mediated signaling in anergic T cells.
Migita K; Eguchi K; Kawabe Y; Tsukada T; Ichinose Y; Nagataki S; Ochi A
J Immunol; 1995 Dec; 155(11):5083-7. PubMed ID: 7594516
[TBL] [Abstract][Full Text] [Related]
34. Anergy induction by dimeric TCR ligands.
Appel H; Seth NP; Gauthier L; Wucherpfennig KW
J Immunol; 2001 Apr; 166(8):5279-85. PubMed ID: 11290814
[TBL] [Abstract][Full Text] [Related]
35. Regulation of the maintenance of peripheral T-cell anergy by TAB1-mediated p38 alpha activation.
Ohkusu-Tsukada K; Tominaga N; Udono H; Yui K
Mol Cell Biol; 2004 Aug; 24(16):6957-66. PubMed ID: 15282297
[TBL] [Abstract][Full Text] [Related]
36. The inability to disrupt the immunological synapse between infected human T cells and APCs distinguishes HIV-1 from most other primate lentiviruses.
Arhel N; Lehmann M; Clauss K; Nienhaus GU; Piguet V; Kirchhoff F
J Clin Invest; 2009 Oct; 119(10):2965-75. PubMed ID: 19759518
[TBL] [Abstract][Full Text] [Related]
37. CTLA-4 is not required for induction of CD8(+) T cell anergy in vivo.
Frauwirth KA; Alegre ML; Thompson CB
J Immunol; 2001 Nov; 167(9):4936-41. PubMed ID: 11673499
[TBL] [Abstract][Full Text] [Related]
38. CD4-CD8-C.B-17 SCID thymocytes enter the CD4+CD8+ stage in the presence of neonatally grafted T cells.
Schneider MK; Grönvik KO
Scand J Immunol; 1998 May; 47(5):466-74. PubMed ID: 9627131
[TBL] [Abstract][Full Text] [Related]
39. Antigen, in the presence of TGF-beta, induces up-regulation of FoxP3gfp+ in CD4+ TCR transgenic T cells that mediate linked suppression of CD8+ T cell responses.
Kapp JA; Honjo K; Kapp LM; Goldsmith K; Bucy RP
J Immunol; 2007 Aug; 179(4):2105-14. PubMed ID: 17675469
[TBL] [Abstract][Full Text] [Related]
40. Distinct requirements for C-C chemokine and IL-2 production by naive, previously activated, and anergic T cells.
Lerner CG; Horton MR; Schwartz RH; Powell JD
J Immunol; 2000 Apr; 164(8):3996-4002. PubMed ID: 10754290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
